Screening for Lung Cancer High-risk Groups

Kubík, Antonín
June 1970
British Medical Journal;6/13/1970, Vol. 2 Issue 5710, p666
Academic Journal
No abstract available.


Related Articles

  • 2011 - Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney disease. Laville, Maurice // ACP Journal Club;11/15/2011, Vol. 155 Issue 5, p1 

    The article focuses on a study which examined the effects of simvastatin plus ezetimibe in patients with chronic kidney disease. Information on the dosing regimen is provided. Results of the study showed that the simvastatin plus ezetimibe treatment regimen was effective than placebo in reducing...

  • Lung Cancer Screening Guidelines. Lehto, Rebecca H. // Clinical Journal of Oncology Nursing;Jun2014, Vol. 18 Issue 3, p338 

    Although the third leading cancer in incidence following breast and prostate, lung cancer is the principal cause of cancer death in the United States. The majority of lung cancer cases are detected at an advanced stage when surgical resection is no longer an option. Recent research has concluded...

  • Lung cancer screening with chest radiography has no effect on lung cancer incidence or mortality. Fenton, Joshua J. // Evidence Based Medicine;Oct2012, Vol. 17 Issue 5, p149 

    The author comments on the study "Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial," by M.M. Oken and colleagues revealing that lung cancer incidence and death rates were similar in never, former and current smokers, and...

  • Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts. Tammemägi, Martin C.; Church, Timothy R.; Hocking, William G.; Silvestri, Gerard A.; Kvale, Paul A.; Riley, Thomas L.; Commins, John; Berg, Christine D. // PLoS Medicine;Dec2014, Vol. 11 Issue 12, p1 

    : Martin Tammemägi and colleagues evaluate which risk groups of individuals, including nonsmokers and high-risk individuals from 65 to 80 years of age, should be screened for lung cancer using computed tomography. Please see later in the article for the Editors' Summary

  • Annual LDCT Lung Cancer Screening May Help Those At Risk--But at What Cost? Ranger, Laurel Mckee // Pulmonary Reviews;Jul2012, Vol. 17 Issue 6, p1 

    The article presents a study that identifies which groups are most likely to benefit from lung cancer screening and in what setting would it be most effective. The study revealed that low-dose CT (LDCT) screening for lung cancer may benefit older, high-risk patients due to smoking exposure and...

  • 2011 - Screening with low-dose computed tomography reduced lung cancer mortality in high-risk patients. Gross, Cary P. // ACP Journal Club;11/15/2011, Vol. 155 Issue 5, p5 

    The article focuses on a study which examined whether low-dose computed tomography (CT) screening can reduce lung cancer mortality in high-risk patients. Information on the smoking history of patients is provided, along with adherence to screening in the CT and radiography groups. Results of the...

  • Low-Dose Computed Tomography Screening for Lung Cancer. Soylemez Wiener, Renda // Annals of Internal Medicine;3/17/2015, Vol. 162 Issue 6, p460 

    The article discusses a study on computed tomography (LDCT) screening for lung cancer and mentions topics including persons living in rural communities having high-risk for lung cancer, recommendation for shared decision making for LDCT screening, and need to maintain a registry of persons.

  • Should Family Physicians Routinely Screen for Lung Cancer in High-Risk Populations? SEEHUSEN, DEAN A. // American Family Physician;7/15/2014, Vol. 90 Issue 2, p74C 

    The author views that family physicians should not routinely screen for lung cancer in high-risk populations. Argument is raised against the level B recommendation issued by the U.S. Preventive Services Task Force (USPSTF) for annual computed tomography-based lung cancer screening. Other issues...

  • When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening. Bach, Peter B.; Gould, Michael K. // Annals of Internal Medicine;10/16/2012, Vol. 157 Issue 8, p571 

    The authors discuss the benefits of lung cancer screening with reference to the National Lung Screening Trial (NLST). They report that the risk for the lung cancer death in the high-risk patients reduced by 20 percent after three rounds of annual medical screening with low-radiation-dose...

  • Should Family Physicians Routinely Screen for Lung Cancer in High-Risk Populations? GERBER, DAVID E. // American Family Physician;7/15/2014, Vol. 90 Issue 2, p74A 

    The author agrees that family physicians should routinely screen for lung cancer in high-risk populations. Findings from the National Lung Screening Trial (MLST) and its relevance in the context of other cancer screening efforts are discussed. The author refers to smoking cessation as the best...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics